MedPath

Protein Intake and Resistance Training in Aging

Not Applicable
Completed
Conditions
Frail Elderly Syndrome
Registration Number
NCT01890382
Lead Sponsor
University of Sao Paulo
Brief Summary

Resistance training combined with protein or amino acids supplementation has been shown to be promising for mitigating age-related disabilities and comorbidities. Randomized controlled trials supporting this possibility are still scarce. These series of clinical trials aim to investigate the chronic effects of different strategies of protein and derivatives supplementation in association with resistance training on selected health-related parameters in pre-frail and frail elderly.This is a 16-month, double-blind, randomized, placebo-controlled, parallel-group clinical trial involving a series of investigations. Participants will be divided into nine groups, allowing the assessement of the effects of (1) isolated leucine supplementation; (2) protein source (whey vs. soy); (3) combination of whey protein and creatine; and (4) sexual dimorphism to the response of protein intake plus resistance training (men vs. women). All participants will undergo a supervised, resistance training program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • elderly people
  • frailty or pre-frailty, according to Fried et al., (2001) criteria.
Exclusion Criteria
  • on exogenous insulin and steroid-based drugs
  • chronic obstructive pulmonary disease or respiratory failure
  • use of protein and /or amine-based dietary supplements
  • on restrictive diets (e.g. calorie or food group restrictions)
  • on resistance training
  • untreated cardiovascular, metabolic, or other chronic disease
  • any musculoskeletal condition precluding resistance training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
muscle function4 months

assessed by a battery of physical tests

lean mass4 months

assessed by Dual-energy X-ray absorptiometry

Secondary Outcome Measures
NameTimeMethod
insulin sensitivity4 months

assessed by homeostasis model assessment (HOMA index)

health related-quality of life4 months

assessed by Short-Form Health Survey (SF-36) (score range: 0 to 100, higher values mean better quality of life)

bone mass4 months

assessed by Dual-energy X-ray absorptiometry

Trial Locations

Locations (1)

University of Sao Paulo

🇧🇷

Sao Paulo, Brazil

University of Sao Paulo
🇧🇷Sao Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.